Links to publications that use this peptide:
Holleran et al. Photolabelling the urotensin II receptor reveals distinct agonist- and partial-agonist-binding sitesBiochem J. 2007 Feb 15;402(1):51-61.
Kemp et al. Urotensin II: a novel vasoactivemediator linked to chronic liver disease and portal hypertensionLiver Int. 2007 Nov;27(9):1232-9.
Joyal et al. Urotensin-II levels in acute coronary syndromes.Int J Cardiol. 2006 Mar 22;108(1):31-5.
Rademaker et al. Endogenous urocortins reduce vascular tone and renin-aldosterone/endothelin activity in experimental heart failure.Eur Heart J. 2005 Oct;26(19):2046-54.
Qi et al. Characterization of functional urotensin II receptors in human skeletal muscle myoblasts: comparison with angiotensin II receptors.Peptides. 2005 Apr;26(4):683-90.
Brailoiu et al. The vasoactive peptide urotensin II stimulates spontaneous release from frog motor nerve terminals.Br J Pharmacol. 2003 Apr;138(8):1580-8.
Rademaker et al. Beneficial hemodynamic, endocrine, and renal effects of urocortin in experimental heart failure: comparison with normal sheep.J Am Coll Cardiol. 2002 Oct 16;40(8):1495-505.